• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

RBC Transfusion

Multi-Country Review of ABO-Incompatible Red Blood Cell Transfusions

Safety measures to prevent ABO-incompatible red blood cell (RBC) transfusions are in place throughout the entire process from blood donation…

November 26, 2024

Wide Variations in Treatments and Outcomes Globally in Hemolytic Disease of the Fetus and Newborn

Hemolytic disease of the fetus and newborn (HDFN) is a life-threatening disorder in which maternal alloantibodies destroy fetal and neonatal…

November 19, 2024

RHD Genotyping May Enable D-positive RBC Units to be Transfused to Patients with Anti-D

Patients with sickle cell disease (SCD) often require chronic red blood cell exchanges. The American Society for Hematology recommends matching…

November 13, 2024

Intravenous vs Oral Iron for Pregnant Women in Africa

Worldwide, almost 40% of all pregnant women are anemic (hemoglobin < 11 g/dL) with the percentage rising to around 50%…

November 7, 2024

Liberal Transfusion Thresholds for Patients with Acute Brain Injury

Over the past 25 years, >45 randomized clinical trials have shown that a restrictive transfusion strategy is best for most…

October 17, 2024

RBCs Regulate Hemostasis Through Platelet-Dependent and -Independent Mechanisms

Red blood cells (RBCs) deliver oxygen to tissues and also contribute to hemostasis and thrombosis through platelet interactions that promote…

October 9, 2024

Liberal Transfusion Threshold of 9-10 g/dL for Patients with Myocardial Infarction

While restrictive transfusion hemoglobin (Hb) thresholds are appropriate for most patients, those with anemia and myocardial infarction (MI) may benefit…

October 2, 2024

Prevalence and Trends of Maternal RBC Alloimmunization in the U.S.

Maternal alloimmunization to RBC antigens, whether from blood transfusion or exposure to fetal antigens during pregnancy, can lead to hemolytic…

September 4, 2024

Tranexamic Acid Does Not Reduce Bleeding or Transfusions in Patients Undergoing Liver Resection

Tranexamic acid is a synthetic compound that prevents fibrin clot degradation and has been shown to reduce blood loss and…

August 27, 2024

Nipocalimab Delays Intrauterine Transfusions for Severe Hemolytic Disease of the Fetus and Newborn

Severe hemolytic disease of the fetus and newborn (HDFN) results from red blood cell (RBC) antigen incompatibility when IgG molecules…

August 14, 2024

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Interim pages omitted …
  • Page 21
  • Go to Next Page »

Primary Sidebar

Latest News

  • New Erythropoietin Gene Variants Linked to Hereditary Erythrocytosis

  • Multifaceted Threats to the Blood Supply from Climate Change

  • Distinct Roles for Differently Aged Platelets

  • Anemia Treatment Bundle Improves Hemoglobin Recovery after Critical Illness

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley